Nanobiotix S.A. Employee Benefits Expense
Nanobiotix S.A. (NBTX) reported Employee Benefits Expense of EUR 24.43 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:EmployeeBenefitsExpense · last filed 2026-03-31
| Period end | Employee Benefits Expense 6 month | Employee Benefits Expense 12 month |
|---|---|---|
| 2025-12-31 | 24.43M EUR 20-F · filed 2026-03-31 | |
| 2025-06-30 | 13.47M EUR 6-K · filed 2025-09-30 | |
| 2024-12-31 | 24.33M EUR 20-F · filed 2026-03-31 | |
| 2024-06-30 | 12.54M EUR 6-K · filed 2025-09-30 | |
| 2023-12-31 | 22.49M EUR 20-F · filed 2026-03-31 | |
| 2023-06-30 | 10.53M EUR 6-K · filed 2024-09-18 | |
| 2022-12-31 | 20.56M EUR 20-F · filed 2025-04-02 | |
| 2022-06-30 | 10.64M EUR 6-K · filed 2023-09-26 | |
| 2021-12-31 | 18.98M EUR 20-F · filed 2024-04-24 | |
| 2021-06-30 | 9.95M EUR 6-K · filed 2022-09-28 | |
| 2020-12-31 | 18.09M EUR 20-F · filed 2023-04-24 | |
| 2020-06-30 | 9.04M EUR 6-K · filed 2021-09-08 | |
| 2019-12-31 | 21.18M EUR 20-F · filed 2022-04-08 | |
| 2018-12-31 | 15.70M EUR 20-F/A · filed 2021-04-08 |